Prognostic value of Ki67 and PSA-immunostaining in de novo metastatic hormone-sensitive prostate cancer. Arch Ital Urol Androl [Internet]. 2026 Mar. 31 [cited 2026 Apr. 20];98(1). Available from: https://www.pagepressjournals.org/aiua/article/view/14731